iTeos Therapeutics, Inc. ( ITOS) - Key Metrics
Stock symbol ITOS is outdated, potentially delisted? Maybe it is available on other exchange?
ITOS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | ? | -$0.80 | -$0.78 | -$0.78 |
| 2024Q4 | ? | -$1.08 | $0.14 | $0.13 |
| 2024Q3 | ? | -$1.05 | -$0.87 | -$0.87 |
| 2024Q2 | $0.88 | -$0.18 | -$0.85 | -$0.87 |
| 2024Q1 | ? | -$1.07 | -$0.90 | -$0.93 |
ITOS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -1.86 |
| 2024Q4 | ? | -1.78 |
| 2024Q3 | ? | -2.43 |
| 2024Q2 | ? | -20.90 |
| 2024Q1 | ? | -3.13 |
ITOS
Price: $10.15
52 week price:
Earnings Per Share: -4.73 USD
P/E Ratio: -2.15
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 231111
Market Capitalization: 448.7 million